Federal Rescheduling: What Operators Need to Know
DEA rulemaking, 280E sunset, banking reform, and the legal landscape after Schedule III
Robert Hoban, Esq.
Cannabis Law Counsel — Hoban Law Group
What you will learn
- ✓Explain the DEA rulemaking process for rescheduling and current status
- ✓Advise clients on 280E implications during the transition period
- ✓Analyze banking and financial services changes under Schedule III
- ✓Identify unresolved FDA regulatory authority questions
Course Content — 3 Modules
Module content unlocks after purchase.
DEA Rulemaking: Process, Timeline, and Current Status
The formal rulemaking process for cannabis rescheduling — HHS recommendation, DEA proposed rule, public comment, and finalization.
280E Sunset, Banking Reform, and Financial Services
The federal tax and banking landscape after rescheduling — what changes, what does not, and how to advise clients during the transition.
FDA Regulatory Authority, Advertising, and State Law Interaction
Unresolved questions about FDA jurisdiction over Schedule III cannabis, advertising restrictions, and how federal rescheduling interacts with state regulatory frameworks.
$99
1 general CLE
Monitor subscribers: 20% off applied at checkout.
- ✓Lifetime access to course materials
- ✓3 video lessons + quiz
- ✓Downloadable CLE certificate
- ✓1 CLE credits
Already enrolled?
Access my course →